Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Yerly

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
Transfusion|February 1, 1993
Human immunodeficiency virus type 1 nucleic acids detected before p24 antigenemia in a blood donorP de Saussure, S Yerly, E Tullen, et al.
AIDS (London, England)|October 9, 1998
Use of highly sensitive assays for the evaluation of post-exposure HIV prophylaxisG A Schockmel, J F Balavoine, S Yerly, et al.
Antiviral Therapy|August 1, 1996
Predictive value of codon 215 reverse transcriptase mutation on the efficacy of didanosine in HIV-infected, zidovudine-experienced patientsS Yerly, N Denereaz, B Mermillod, et al.
Acta Tropica|May 1, 1990
Development of a haptoglobin ELISA. Its use as an indicator for malariaS Yerly, M Bouvier, A Rougemont, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 1, 1995
Early and prolonged decrease of viremia in HIV-1-infected patients treated with didanosineS Yerly, L Kaiser, C Baumberger, et al.
AIDS (London, England)|January 12, 2001
Decay of cell-associated HIV-1 DNA correlates with residual replication in patients treated during acute HIV-1 infectionS Yerly, T V Perneger, S Vora, et al.
Revue Medicale Suisse|May 24, 2013
[The post-exposure prophylaxis in all its forms]N Wassilew, E Boffi El Amari, C Bonfillon, et al.
The Journal of Infectious Diseases|November 1, 1991
Absence of chronic human immunodeficiency virus infection without seroconversion in intravenous drug users: a prospective and retrospective studyS Yerly, E Chamot, J J Déglon, et al.
Antiviral Therapy|January 26, 2002
Drug resistance mutations in HIV-1-infected subjects during protease inhibitor-containing highly active antiretroviral therapy with nelfinavir or indinavirS Yerly, M Rickenbach, M Popescu, et al.
Journal of Clinical Microbiology|January 1, 1996
Rapid and sensitive detection of enteroviruses in specimens from patients with aseptic meningitisS Yerly, A Gervaix, V Simonet, et al.
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
Transfusion|February 1, 1993
Human immunodeficiency virus type 1 nucleic acids detected before p24 antigenemia in a blood donorP de Saussure, S Yerly, E Tullen, et al.
AIDS (London, England)|October 9, 1998
Use of highly sensitive assays for the evaluation of post-exposure HIV prophylaxisG A Schockmel, J F Balavoine, S Yerly, et al.
Antiviral Therapy|August 1, 1996
Predictive value of codon 215 reverse transcriptase mutation on the efficacy of didanosine in HIV-infected, zidovudine-experienced patientsS Yerly, N Denereaz, B Mermillod, et al.
Acta Tropica|May 1, 1990
Development of a haptoglobin ELISA. Its use as an indicator for malariaS Yerly, M Bouvier, A Rougemont, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 1, 1995
Early and prolonged decrease of viremia in HIV-1-infected patients treated with didanosineS Yerly, L Kaiser, C Baumberger, et al.
AIDS (London, England)|January 12, 2001
Decay of cell-associated HIV-1 DNA correlates with residual replication in patients treated during acute HIV-1 infectionS Yerly, T V Perneger, S Vora, et al.
Revue Medicale Suisse|May 24, 2013
[The post-exposure prophylaxis in all its forms]N Wassilew, E Boffi El Amari, C Bonfillon, et al.
The Journal of Infectious Diseases|November 1, 1991
Absence of chronic human immunodeficiency virus infection without seroconversion in intravenous drug users: a prospective and retrospective studyS Yerly, E Chamot, J J Déglon, et al.
Antiviral Therapy|January 26, 2002
Drug resistance mutations in HIV-1-infected subjects during protease inhibitor-containing highly active antiretroviral therapy with nelfinavir or indinavirS Yerly, M Rickenbach, M Popescu, et al.
Journal of Clinical Microbiology|January 1, 1996
Rapid and sensitive detection of enteroviruses in specimens from patients with aseptic meningitisS Yerly, A Gervaix, V Simonet, et al.
Pageof 9